ACTA1 and cancer: A subsequent analysis revealed that cancer cells in a bone cavity produced abundantly a chemokine, CCL4, which attracted type I collagen-expressing α-SMA+ fibroblasts expressing CCR5, a specific receptor for CCL4 [109].